remifentanil has been researched along with 2019 Novel Coronavirus Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bastos, FI; Bianchi, LM; Carvalho, RM; da Cunha, AJLA; de Magalhães-Barbosa, MC; Prata-Barbosa, A; Rodrigues-Santos, G | 1 |
| Bevilacqua, S; Bottari, V; Galeotti, I | 1 |
| Tang, LY; Wang, J | 1 |
3 other study(ies) available for remifentanil and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Shift in hospital opioid use during the COVID-19 pandemic in Brazil: a time-series analysis of one million prescriptions.
Topics: Adult; Analgesics, Opioid; Brazil; COVID-19; Fentanyl; Humans; Methadone; Morphine; Opioid-Related Disorders; Pandemics; Prescriptions; Remifentanil; Sufentanil; Tramadol | 2023 |
Systematic Application of Rapid Sequence Intubation With Remifentanil During COVID-19 Pandemic.
Topics: COVID-19; Humans; Intubation, Intratracheal; Remifentanil; SARS-CoV-2 | 2021 |
Response to "Systematic Application of Rapid Sequence Intubation With Remifentanil During COVID-19 Pandemic".
Topics: COVID-19; Humans; Pandemics; Rapid Sequence Induction and Intubation; Remifentanil; SARS-CoV-2 | 2021 |